John de Kruif

Chief Tech/Sci/R&D Officer chez MERUS N.V.

60 ans

Health Technology

Consumer Services

Postes actifs de John de Kruif

Sociétés	Poste	Début	Fin
MERUS N.V.	Chief Tech/Sci/R&D Officer	01/04/2007	-

Sociétés	Poste	Début	Fin
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Corporate Officer/Principal	01/10/2000	01/10/2006

University of Utrecht

Doctorate Degree

Internationale

Pays-Bas

Opérationnelle

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Doctorate Degree	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
MERUS N.V.	Health Technology

Entreprise privées	1
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Health Technology

Entreprise privées

Health Technology